Wednesday, March 6, 2013

• PDLI Beats on Higher RevenuesZacks (Wed, Mar 6)
• Legendary Drug Industry Executives Warn U.S. Science Cuts Endanger The Futureat Forbes (Wed, Mar 6)

Tuesday, March 5, 2013

• Is Apple/Genentech's Art Levinson Poised to Assume Chairman Role at Roche?at Forbes (Tue, Mar 5)
• Vertex flu treatment may become large franchise, says William Blairat theflyonthewall.com (Tue, Mar 5)
• Vertex flu treatment may become large franchise, says William Blairtheflyonthewall.com (Tue, Mar 5)

Friday, March 1, 2013

• Roche Teams Up with BiocareZacks (Fri, Mar 1)
• Preclinical Biotech Structured Deals: Reflections on 2013's Solid Startat Forbes (Fri, Mar 1)
• Testis Compositum: Pistorius' Medicine Not Medicineat Forbes (Fri, Mar 1)

Wednesday, February 27, 2013

• Pipeline Progresses at RocheZacks (Wed, Feb 27)

Tuesday, February 26, 2013

• Ventana and Biocare Medical sign p63 license agreement to aid in the differential diagnosis of benign and malignant prostate lesionsPR Newswire (Tue, Feb 26)

Monday, February 25, 2013

• FDA Approves Roche's KadcylaZacks (Mon, Feb 25)
• Amgen climbs, Affymax plummets following drug recalltheflyonthewall.com (Mon, Feb 25)

Sunday, February 24, 2013

• Genentech: Omalizumab met its primary endpoint in Phase III trial, ASTERIA llltheflyonthewall.com (Sun, Feb 24)
• Phase III Results Showed omalizumab Significantly Reduced Disease Severity in Patients with a Chronic Form of Hives who Failed Standard TherapyBusiness Wire (Sun, Feb 24)

Friday, February 22, 2013

• Roche Breast Cancer Drug To Succeed Herceptinat Investor's Business Daily (Fri, Feb 22)
• Roche, ImmunoGen Breast Cancer Drug Wins Approvalat Investor's Business Daily (Fri, Feb 22)
• Roche confirms FDA approval for Kadcylaat theflyonthewall.com (Fri, Feb 22)
• FDA Approves Genentech’s Kadcyla (Ado-Trastuzumab Emtansine), the First Antibody-Drug Conjugate for Treating HER2-Positive Metastatic Breast CancerBusiness Wire (Fri, Feb 22)

Wednesday, February 20, 2013

• Roche Collaborates with ChiasmaZacks (Wed, Feb 20)

Monday, February 18, 2013

• Roche and Chiasma announce collaboration to develop and commercialize Chiasma's Octreolin® for acromegaly and neuroendocrine tumorsPR Newswire (Mon, Feb 18)

Sunday, February 17, 2013

• AbbVie suspends Leukemia therapy trials. Bloomberg reportstheflyonthewall.com (Sun, Feb 17)

Friday, February 15, 2013

• Roche's Worth $58 On Continued Growth And Strong Pipelineat Forbes (Fri, Feb 15)
• Revenues Rise at IncyteZacks (Fri, Feb 15)

Wednesday, February 13, 2013

• Roche Collaborates with RQx PharmaZacks (Wed, Feb 13)

Tuesday, February 12, 2013

• RQx Pharmaceuticals and Genentech Enter Drug Discovery Collaboration to Develop Novel Drug CompoundsPR Newswire (Tue, Feb 12)

Add RHHBY News to My Yahoo!